alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

April 12, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-1644

EQI, Ltd: 

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at

https://ustr.gov/sites/default/files/enforcement/301Investigations/Notice_of_Product_Exclusions

_04.15.19.pdf.

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs products covered by a specially drafted description contained in the annex to 

the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation.

Sincerely,

Stephen P. Vaughn

General Counsel
Opinion issued June 23, 2022

In The

Court of Appeals 

For The 

First District of Texas 

————————————

NO. 01-22-00206-CR

———————————

IN RE J.B. BLACK, Relator

Original Proceeding on Petition for Writ of Mandamus

MEMORANDUM OPINION

J.B. Black, acting pro se, has filed a petition for writ of mandamus compelling 

the trial court to rule on his motion for appointment of new counsel.1 We deny the 

petition.

PER CURIAM

Panel consists of Chief Justice Radack and Justices Goodman and Hightower.

Do not publish. TEX. R. APP. P. 47.2(b).

1 The underlying case is The State of Texas v. J.B. Black, cause number 1723527, 

pending in the 174th District Court of Harris County, Texas, the Honorable Hazel 

B. Jones presiding.
40.76 ±0.1 

 6 ±0.1 

 

51.15

50.85

 35 ±0.15 

 10.60 ±0.1 

R9 ±0

.1

 4.40 ±0.1 

 20 ±0.1 

 6.30 ±0.1 

 13 ±0.1 

 1.80 ±0.1 

2 PLACE ±0.05mm1 PLACE ±0.1mm0 PLACE ±0.5mmSTANDARD STD-GEN-026TOLERANCES ARE REGULATED BY UNILATERAL AND OFFSET BILATERAL TOLERANCES:  : INDICATES A CRITICAL CHARACANGLES ±5°

NAME DATE

DRAWNCHECKEDAPPROVED

D
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUL-31-2001
<PERIOD-END>                               OCT-31-2000
<CASH>                                      11,915,573
<SECURITIES>                                17,702,001
<RECEIVABLES>                                   15,587
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            29,883,960
<PP&E>                                       2,977,534
<DEPRECIATION>                                 222,046
<TOTAL-ASSETS>                              36,710,775
<CURRENT-LIABILITIES>                        1,419,635
<BONDS>                                        686,162
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          1
<COMMON>                                    57,874,762
<OTHER-SE>                                    (54,118)
<TOTAL-LIABILITY-AND-EQUITY>                36,710,775
<SALES>                                              0
<TOTAL-REVENUES>                             1,000,000
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             2,344,532
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                            (19,620)
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,144,207)
<EPS-BASIC>                                     (0.07)
<EPS-DILUTED>                                   (0.07)


</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                           1,541
<SECURITIES>                                         0
<RECEIVABLES>                                   51,090
<ALLOWANCES>                                     5,917
<INVENTORY>                                      1,689
<CURRENT-ASSETS>                                54,973
<PP&E>                                         150,598
<DEPRECIATION>                                  57,068
<TOTAL-ASSETS>                                 347,408
<CURRENT-LIABILITIES>                           31,340
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           282
<OTHER-SE>                                     298,966
<TOTAL-LIABILITY-AND-EQUITY>                   347,408
<SALES>                                        348,870
<TOTAL-REVENUES>                               348,870
<CGS>                                           53,711
<TOTAL-COSTS>                                   53,711
<OTHER-EXPENSES>                               183,807
<LOSS-PROVISION>                                 3,472
<INTEREST-EXPENSE>                                 497
<INCOME-PRETAX>                                106,996
<INCOME-TAX>                                    40,422
<INCOME-CONTINUING>                             66,574
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    66,574
<EPS-PRIMARY>                                     2.31
<EPS-DILUTED>                                     2.31
        

</TABLE>
CONSENT OF INDEPENDENT AUDITOR


We consent to the incorporation by reference in this Form 10-KSB of WhatsForFree
Technologies, Inc. (formerly Ranes International Holding, Inc.) (A Development
Stage Enterprise) of our report dated March 17, 2000, relating to the balance
sheets of WhatsForFree Technologies, Inc. (formerly Ranes International Holding,
Inc.) (A Development Stage Enterprise) as of December 31, 1999 and the related
statement of operations, stockholders' equity, and cash flows for each of the
three years in the period then ended, and for the cumulative period from
February 15, 1990 (inception) through December 31, 1999.

We also consent to the addition of the financial statement data schedule, listed
in the accompanying Index to Financial Statements and Financial Statement
Schedule, to the financial statements covered by our report dated March 17,
2000.





 /s/ Timothy L. Steers, CPA, LLC

TIMOTHY L. STEERS
CERTIFIED PUBLIC ACCOUNTANT, LLC

Portland, Oregon
March 17, 2000
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          14,935
<SECURITIES>                                         0
<RECEIVABLES>                                  107,375
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               219,171
<PP&E>                                         407,120
<DEPRECIATION>                                 269,146
<TOTAL-ASSETS>                               3,742,108
<CURRENT-LIABILITIES>                        1,444,372
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                         10
<COMMON>                                        27,044
<OTHER-SE>                                   2,270,682
<TOTAL-LIABILITY-AND-EQUITY>                 3,742,108
<SALES>                                        139,612
<TOTAL-REVENUES>                               139,612
<CGS>                                           67,671
<TOTAL-COSTS>                                1,063,563
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               6,960
<INCOME-PRETAX>                               (930,911)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (930,911)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (930,911)
<EPS-BASIC>                                       (.04)
<EPS-DILUTED>                                     (.04)


</TABLE>
**EXHIBIT
      23.1**











**CONSENT
      OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**


We
      consent to the incorporation by reference in the Registration Statements on
      Forms S-3 (No. 333-106608, No. 333-108924, No. 333-110754, No. 333-110752,
      No.
      333-82496, No. 333-91225, No. 333-91235, No. 333-17105, No. 333-122391, No.
      333-122392, No. 333-133828, No. 333-134626, No. 333-132048 and No. 333-137100))
      and Forms S-8 (No. 333-109595, No. 333-91259, No. 333-137447 and No. 333-122393)
      of SpatiaLight, Inc. of our reports dated March 15, 2007 relating to the
      consolidated financial statements of SpatiaLight, Inc. (which report expresses
      an unqualified opinion and includes a matter of emphasis paragraph relating
      to
      the Company’s ability to continue as a going concern), SpatiaLight, Inc.
      management's assessment of the effectiveness of internal control over financial
      reporting, and the effectiveness of internal control over financial reporting
      (which report expresses an adverse opinion on the effectiveness of the Company’s
      internal controls over financial reporting because of material weaknesses)
      of
      SpatiaLight, Inc., included in this Annual Report on Form  10-K for the
      year ended December 31, 2006.











ODENBERG,
      ULLAKKO, MURANISHI & CO. LLP





San
      Francisco, California


March 15,
      2007


95
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-START>                             OCT-01-2000
<PERIOD-END>                               JUN-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                         472,183
<SECURITIES>                                    97,438
<RECEIVABLES>                                2,799,934
<ALLOWANCES>                                   114,000
<INVENTORY>                                          0
<CURRENT-ASSETS>                             4,418,431
<PP&E>                                       3,446,570
<DEPRECIATION>                                 840,103
<TOTAL-ASSETS>                              12,668,030
<CURRENT-LIABILITIES>                        7,151,320
<BONDS>                                      3,610,686
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        13,148
<OTHER-SE>                                   3,433,707
<TOTAL-LIABILITY-AND-EQUITY>                12,668,030
<SALES>                                              0
<TOTAL-REVENUES>                            10,752,374
<CGS>                                                0
<TOTAL-COSTS>                                9,781,218
<OTHER-EXPENSES>                             4,544,848
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             617,192
<INCOME-PRETAX>                            (4,321,403)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (4,321,403)
<DISCONTINUED>                               1,055,510
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (3,265,893)
<EPS-BASIC>                                     (0.25)
<EPS-DILUTED>                                   (0.25)


</TABLE>
Exhibit 10.46  EXECUTION COPY  ***Text
Omitted and Filed Separately with
the Securities and Exchange Commission. Confidential
Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4)
and 240.24b-2  AMENDMENT TO THE COMMERCIAL SUPPLY AGREEMENT  THIS AMENDMENT TO THE COMMERCIAL SUPPLY
AGREEMENT (the Amendment) is made and entered into effective as of December 8,
2008 (the Amendment Date), by and between Amylin Pharmaceuticals, Inc.
(Amylin) and Baxter Pharmaceutical Solutions LLC (Baxter).
Capitalized terms used in this Amendment that are not otherwise defined herein
shall have the meanings ascribed to such terms in the Agreement (as defined
herein).  WHEREAS, effective February 14, 2005,
Amylin and Baxter entered into that certain Commercial Supply Agreement (the Agreement)
wherein Baxter agreed to produce the Exenatide BID Product for Amylin pursuant
to the terms and conditions contained therein; and  WHEREAS, Amylin and Baxter desire to amend
the Agreement as set forth herein with respect to Amylins Annual Obligation.  NOW, THEREFORE, Amylin and Baxter agree as
follows:  As of the Amendment Date,
Amylin and Baxter agree that Exhibit F, as attached to the Agreement prior
to the Amendment Date, shall be deleted and replaced with Exhibit F-1,
attached to this Amendment.  The other provisions of the Agreement, not
amended by this Amendment, remain in full force and effect.  This Amendment may be executed in
counterparts and all such counterparts shall be treated as one and the same document.  IN WITNESS WHEREOF, Amylin and Baxter have
executed this Amendment as of the date first above written.  AMYLIN PHARMACEUTICALS, INC.
  BAXTER PHARMACEUTICALSOLUTIONS LLCBy:
  /S/ PAUL
  MARSHALL
  
  By:
  /S/ BRIK V.
  EYREName:
  Paul
  Marshall
  
  Name:
  Brik V. EyreTitle:
  Vice
  President, Operations
  
  Title:
  General
  ManagerDate:
  01/07/2009
  
  Date:
  01/12/2009


Exhibit F-1  Annual Obligation  YEAR
  
  ANNUAL OBLIGATIONFirst calendar year following Regulatory
  Approval (2006)
  
  [***]Second calendar year following Regulatory
  Approval (2007)
  
  [***]Third calendar year following Regulatory
  Approval (2008)
  
  [***]Fourth calendar year following Regulatory
  Approval (2009)
  
  [***]Fifth calendar year following Regulatory
  Approval (2010)
  
  [***]Sixth calendar year following Regulatory
  Approval (2011)
  
  [***]  ***Confidential Treatment Requested
<PAGE>

                                  EXHIBIT 11

                          DURA PHARMACEUTICALS, INC.
           STATEMENTS RE COMPUTATIONS OF NET INCOME (LOSS) PER SHARE

<TABLE>
<CAPTION>
                                                                YEAR ENDED DECEMBER 31,
                                               ---------------------------------------------------------
                                                  1996                   1997                   1998
                                               ------------          ------------           ------------
<S>                                            <C>                   <C>                    <C>
 NET INCOME (LOSS)
  PER SHARE - BASIC

Net Income (Loss)                              $ 24,328,000          $(84,692,000)          $  2,733,000
                                               ------------          ------------           ------------

Weighted Average Number of
  Common and Common Equivalent
  Shares:
    Common Stock Outstanding                     35,834,714            43,828,208             46,028,396
                                               ------------          ------------           ------------

Net Income (Loss) Per Share - Basic            $       0.68          $      (1.93)          $       0.06
                                               ------------          ------------           ------------
                                               ------------          ------------           ------------

NET INCOME (LOSS)
  PER SHARE - DILUTED

Net Income (Loss)                              $ 24,328,000          $(84,692,000)          $  2,733,000
                                               ------------          ------------           ------------

Weighted Average Number of
  Common and Common Equivalent
  Shares Assuming Issuance of All
  Dilutive Contingent Shares:
    Common Stock Outstanding                     35,834,714            43,828,208             46,028,396
    Stock Options                                 1,772,250                    --                744,155
    Warrants                                      2,872,044                    --              1,036,440
                                               ------------          ------------           ------------
        Total                                    40,479,008            43,828,208             47,808,991
                                               ------------          ------------           ------------
                                               ------------          ------------           ------------

Net Income (Loss) Per Share - Diluted          $       0.60          $      (1.93)          $       0.06
                                               ------------          ------------           ------------
                                               ------------          ------------           ------------
</TABLE>
[Federal Register Volume 60, Number 6 (Tuesday, January 10, 1995)]
[Notices]
[Page 2585]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-498]



-----------------------------------------------------------------------

DEPARTMENT OF ENERGY
[Docket No. GT95-15-000]


Williston Basin Interstate Pipeline Company; Notice of Filing

January 4, 1995.
    Take notice that on December 30, 1994, Williston Basin Interstate 
Pipeline Company (Williston Basin), tendered for filing as part of its 
FERC Gas Tariff, Second Revised Volume No. 1, revised tariff sheets, 
with an effective date of December 30, 1994.
    Williston Basin states that the revised tariff sheets are being 
filed to update its Master Receipt/Delivery Point List.
    Any person desiring to be heard or to protest said filing should 
file a motion to intervene or protest with the Federal Energy 
Regulatory Commission, 825 North Capitol Street, N.E., Washington, D.C. 
20426, in accordance with Rules 211 and 214 of the Commission's Rules 
of Practice and Procedure (18 CFR 385.211 and 385.214). All such 
motions or protests should be filed on or before January 11, 1995. 
Protests will be considered by the Commission in determining the 
appropriate action to be taken, but will not serve to make protestants 
parties to the proceeding. Any person wishing to become a party to the 
proceeding must file a motion to intervene. Copies of this filing are 
on file with the Commission and are available for public inspection.
Linwood A. Watson, Jr.,
Acting Secretary.
[FR Doc. 95-498 Filed 1-9-95; 8:45 am]
BILLING CODE 6717-01-M
Exhibit 21.1**METRETEK TECHNOLOGIES, INC.****List of Subsidiaries**Southern Flow Companies, Inc., a Delaware corporationPowerSecure, Inc., a Delaware corporationIndustrial Automation, Inc., a North Carolina corporationUtilityEngineering, Inc., a North Carolina corporationPowerServices, Inc., a North Carolina corporationEnergyLite, Inc., a Delaware corporationReid’s Trailer, Inc., a Delaware corporationUtilityDesign, Inc., a North Carolina corporationMetretek, Incorporated, a Florida corporationMetretek Contract Manufacturing Company, Inc.Marcum Gas Transmission, Inc., a Colorado corporationMarcum Capital Resources, Inc., a Colorado corporationMarcum Midstream 1995-2 Business Trust, a Delaware statutory trust (Less than majority ownership)PowerSpring, Inc. a Delaware corporationMercator Energy Incorporated, a Colorado corporationMarcum Denver, Inc., a Colorado corporation
<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                                          6-MOS
<FISCAL-YEAR-END>                                JUL-31-1998
<PERIOD-END>                                     JAN-31-1999
<CASH>                                            $3,094,694
<SECURITIES>                                               0 
<RECEIVABLES>                                        209,533 
<ALLOWANCES>                                               0 
<INVENTORY>                                                0 
<CURRENT-ASSETS>                                   3,460,335 
<PP&E>                                             2,439,967 
<DEPRECIATION>                                        60,830 
<TOTAL-ASSETS>                                     6,699,264 
<CURRENT-LIABILITIES>                              1,077,681 
<BONDS>                                              612,380 
<PREFERRED-MANDATORY>                                      0 
<PREFERRED>                                                1 
<COMMON>                                          14,208,777 
<OTHER-SE>                                                 0 
<TOTAL-LIABILITY-AND-EQUITY>                       6,699,264
<SALES>                                                    0 
<TOTAL-REVENUES>                                           0 
<CGS>                                                      0 
<TOTAL-COSTS>                                              0 
<OTHER-EXPENSES>                                   2,781,381 
<LOSS-PROVISION>                                           0 
<INTEREST-EXPENSE>                                    33,574 
<INCOME-PRETAX>                                            0 
<INCOME-TAX>                                               0 
<INCOME-CONTINUING>                                        0 
<DISCONTINUED>                                             0 
<EXTRAORDINARY>                                            0 
<CHANGES>                                                  0 
<NET-INCOME>                                      (2,814,955)
<EPS-PRIMARY>                                          (0.22)
<EPS-DILUTED>                                          (0.22)
                                                             

</TABLE>